<!DOCTYPE html><html class="" lang="en"><head>
    <!-- REQUIRED META INFORMATION -->
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="msapplication-tap-highlight" content="no">

    <meta name="DCTERMS:contentOwner" content="TNeville">
    <meta name="DCTERMS:contentOffice" content="DCRDP:ODP:OMP">

    <meta name="DCTERMS:coder" content="^ORDP Webmaster">
    <meta name="DCTERMS:coderOffice" content="DCRDP:ODEPPIN:OPPS">

    <meta name="description" content="10.00 Multiple Body Systems-Adult">
    <meta name="DCTERMS:dateCertified" content="2019-11-25">

    <!-- DOCUMENT TITLE -->
    <title>1.00 Musculoskeletal Disorders - Adult | Disability | SSA</title>

    <!-- STYLES -->
    <link rel="stylesheet" href="/framework/css/ssa.firefly.css">

    <!-- SCRIPTS -->
    <script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-5GQXH7Q"></script><script src="/framework/js/ssa.firefly.head.js"></script>


    <style>
        table{
        border-collapse:collapse;
        border:1px solid gray;
        }

            table td {
                border: 1px solid gray;
            }
    </style>


<script>(window.BOOMR_mq=window.BOOMR_mq||[]).push(["addVar",{"rua.upush":"false","rua.cpush":"false","rua.upre":"false","rua.cpre":"false","rua.uprl":"false","rua.cprl":"false","rua.cprf":"false","rua.trans":"","rua.cook":"false","rua.ims":"false","rua.ufprl":"false","rua.cfprl":"false","rua.isuxp":"false","rua.texp":"norulematch","rua.ceh":"false","rua.ueh":"false","rua.ieh.st":"0"}]);</script>
                              <script>!function(e){var n="https://s.go-mpulse.net/boomerang/";if("False"=="True")e.BOOMR_config=e.BOOMR_config||{},e.BOOMR_config.PageParams=e.BOOMR_config.PageParams||{},e.BOOMR_config.PageParams.pci=!0,n="https://s2.go-mpulse.net/boomerang/";if(window.BOOMR_API_key="LERZW-HECFS-R8H4E-23UQ7-ERMQB",function(){function e(){if(!o){var e=document.createElement("script");e.id="boomr-scr-as",e.src=window.BOOMR.url,e.async=!0,i.parentNode.appendChild(e),o=!0}}function t(e){o=!0;var n,t,a,r,d=document,O=window;if(window.BOOMR.snippetMethod=e?"if":"i",t=function(e,n){var t=d.createElement("script");t.id=n||"boomr-if-as",t.src=window.BOOMR.url,BOOMR_lstart=(new Date).getTime(),e=e||d.body,e.appendChild(t)},!window.addEventListener&&window.attachEvent&&navigator.userAgent.match(/MSIE [67]\./))return window.BOOMR.snippetMethod="s",void t(i.parentNode,"boomr-async");a=document.createElement("IFRAME"),a.src="about:blank",a.title="",a.role="presentation",a.loading="eager",r=(a.frameElement||a).style,r.width=0,r.height=0,r.border=0,r.display="none",i.parentNode.appendChild(a);try{O=a.contentWindow,d=O.document.open()}catch(_){n=document.domain,a.src="javascript:var d=document.open();d.domain='"+n+"';void(0);",O=a.contentWindow,d=O.document.open()}if(n)d._boomrl=function(){this.domain=n,t()},d.write("<bo"+"dy onload='document._boomrl();'>");else if(O._boomrl=function(){t()},O.addEventListener)O.addEventListener("load",O._boomrl,!1);else if(O.attachEvent)O.attachEvent("onload",O._boomrl);d.close()}function a(e){window.BOOMR_onload=e&&e.timeStamp||(new Date).getTime()}if(!window.BOOMR||!window.BOOMR.version&&!window.BOOMR.snippetExecuted){window.BOOMR=window.BOOMR||{},window.BOOMR.snippetStart=(new Date).getTime(),window.BOOMR.snippetExecuted=!0,window.BOOMR.snippetVersion=12,window.BOOMR.url=n+"LERZW-HECFS-R8H4E-23UQ7-ERMQB";var i=document.currentScript||document.getElementsByTagName("script")[0],o=!1,r=document.createElement("link");if(r.relList&&"function"==typeof r.relList.supports&&r.relList.supports("preload")&&"as"in r)window.BOOMR.snippetMethod="p",r.href=window.BOOMR.url,r.rel="preload",r.as="script",r.addEventListener("load",e),r.addEventListener("error",function(){t(!0)}),setTimeout(function(){if(!o)t(!0)},3e3),BOOMR_lstart=(new Date).getTime(),i.parentNode.appendChild(r);else t(!1);if(window.addEventListener)window.addEventListener("load",a,!1);else if(window.attachEvent)window.attachEvent("onload",a)}}(),"".length>0)if(e&&"performance"in e&&e.performance&&"function"==typeof e.performance.setResourceTimingBufferSize)e.performance.setResourceTimingBufferSize();!function(){if(BOOMR=e.BOOMR||{},BOOMR.plugins=BOOMR.plugins||{},!BOOMR.plugins.AK){var n=""=="true"?1:0,t="",a="im6jsaqxzhbro2ioayqq-f-7c70b0df8-clientnsv4-s.akamaihd.net",i="false"=="true"?2:1,o={"ak.v":"39","ak.cp":"1204614","ak.ai":parseInt("728289",10),"ak.ol":"0","ak.cr":20,"ak.ipv":4,"ak.proto":"h2","ak.rid":"ca151b0","ak.r":39734,"ak.a2":n,"ak.m":"dsca","ak.n":"essl","ak.bpcip":"67.60.153.0","ak.cport":51130,"ak.gh":"23.201.194.23","ak.quicv":"","ak.tlsv":"tls1.3","ak.0rtt":"","ak.0rtt.ed":"","ak.csrc":"-","ak.acc":"","ak.t":"1762526753","ak.ak":"hOBiQwZUYzCg5VSAfCLimQ==h679okCBqfgHcmNPKy3WHO2ZHq6I8uOrEUCFRW5RAoo2b7weIUUhvd3I6hA4mzVeNmCphf6w7r89LeA7bIWt2zJU1oUomd+7iJEkS2/3hH3bxsEsEPZLnxipBjG87ADt/EQqzykmTZQ+5EGaoi7yabkLHHNDzmKBYZakOxX+bmf4VaDjyNi0ZMLhTf3hy8xWdTJMNchw2XWquJ/+rBeVJ4MrzDKQW4MSOaJwA6HYvAkLoC4Zl3O3iUxXVNQ2WR/l847Lq7DhZpfa8YTrV4OgY5oA4Vl6gwZtbKxYMjZguWYg4+HwIeB6tQYAAJ4ROzIqz+LMqH/z9tNs6Bg6CPkBmOpNhFH/Kq/bRhf41C9A7HGK6wL0W4cf1hD+nd2eUH2BxbGVD32oI6+gzR8xIOt6jcGeV0e3DL7Eq6F/8R5JHkA=","ak.pv":"120","ak.dpoabenc":"","ak.tf":i};if(""!==t)o["ak.ruds"]=t;var r={i:!1,av:function(n){var t="http.initiator";if(n&&(!n[t]||"spa_hard"===n[t]))o["ak.feo"]=void 0!==e.aFeoApplied?1:0,BOOMR.addVar(o)},rv:function(){var e=["ak.bpcip","ak.cport","ak.cr","ak.csrc","ak.gh","ak.ipv","ak.m","ak.n","ak.ol","ak.proto","ak.quicv","ak.tlsv","ak.0rtt","ak.0rtt.ed","ak.r","ak.acc","ak.t","ak.tf"];BOOMR.removeVar(e)}};BOOMR.plugins.AK={akVars:o,akDNSPreFetchDomain:a,init:function(){if(!r.i){var e=BOOMR.subscribe;e("before_beacon",r.av,null,null),e("onbeacon",r.rv,null,null),r.i=!0}return this},is_complete:function(){return!0}}}}()}(window);</script><link href="https://s.go-mpulse.net/boomerang/LERZW-HECFS-R8H4E-23UQ7-ERMQB" rel="preload" as="script"><style>@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Light.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Light.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Light.ttf) format("truetype");font-weight:300;font-style:normal;font-display:swap}@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Regular.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Regular.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Regular.ttf) format("truetype");font-weight:400;font-style:normal;font-display:swap}@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-SemiBold.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-SemiBold.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-SemiBold.ttf) format("truetype");font-weight:600;font-style:normal;font-display:swap}@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Bold.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Bold.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-Bold.ttf) format("truetype");font-weight:700;font-style:normal;font-display:swap}@font-face{font-family:"Public Sans Web";src:url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-ExtraBold.woff2) format("woff2"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-ExtraBold.woff) format("woff"),url(https://www.ssa.gov/legacy/components/dist/assets/fonts/public-sans/PublicSans-ExtraBold.ttf) format("truetype");font-weight:800;font-style:normal;font-display:swap}</style><meta property="og:site_name" content="Social Security"><meta property="og:type" content="website"><meta property="og:url" content="https://www.ssa.gov/disability/professionals/bluebook/1.00-Musculoskeletal-Adult.htm"><meta property="og:title" content="1.00 Musculoskeletal Disorders - Adult | Disability | SSA"><meta property="og:description" content="10.00 Multiple Body Systems-Adult"><meta property="og:image:url" content="https://www.ssa.gov/themes/custom/ssa_core/logo.svg"><meta property="og:image:secure_url" content="https://www.ssa.gov/themes/custom/ssa_core/logo.svg"><meta property="og:image:alt" content="U.S. Social Security Administration"><meta property="og:locale" content="en_US"><meta property="og:locale:alternate" content="es_ES"><script id="boomr-scr-as" src="https://s.go-mpulse.net/boomerang/LERZW-HECFS-R8H4E-23UQ7-ERMQB" async=""></script></head>

<body style="margin: 0px;">
  <!-- BANNER -->
  <aside class="accessibility" id="accessibility"><a href="#content" id="skip-navigation">Skip to main content</a></aside>
<!-- WCMS SITE ALERT (EMERGENCY) -->
<div class="wsa" aria-label="Site Alert" data-type="emergency">
  <div class="wsag">
    <svg focusable="false" height="26" width="26" viewBox="0 0 20 20" aria-hidden="true">
      <path fill="#FFFFFF" fill-rule="evenodd" stroke-width="0" d="M10.8,15h-1.7v-1.7h1.7v1.7ZM10.8,11.7h-1.7v-4.9h1.7v4.9Z" vector-effect="non-scaling-stroke"></path>
      <path fill="#1C1D1F" fill-rule="evenodd" stroke-width="0" d="M.8,17.5h18.3L10,1.7.8,17.5ZM10.8,15h-1.7v-1.7h1.7v1.7ZM10.8,11.7h-1.7v-4.9h1.7v4.9h0Z" vector-effect="non-scaling-stroke"></path>
    </svg>
    <div>
      <a href="/myaccount/"><u>Social Security and SSI Payments will Continue during the Government Shutdown.  Visit my Social Security for Online Services.</u></a>
    </div>
  </div>
</div>
<!-- WCMS SITE ALERT (INFORMATION) -->
<div class="wsa" aria-label="Site Alert" data-type="information">
  <div class="wsag">
    <svg focusable="false" height="26" width="26" viewBox="0 0 20 20" aria-hidden="true">
      <path fill="#1C1D1F" fill-rule="evenodd" stroke-width="0" d="M10,1.7C5.4,1.7,1.7,5.4,1.7,10s3.7,8.3,8.3,8.3,8.3-3.7,8.3-8.3S14.6,1.7,10,1.7ZM9.2,7.5v-1.7h1.7v1.7h-1.7ZM9.2,9.2v5h1.7v-5h-1.7Z" vector-effect="non-scaling-stroke"></path>
      <path fill="#FFFFFF" fill-rule="evenodd" stroke-width="0" d="M10.8,7.5h-1.7v-1.7h1.7v1.7Z" vector-effect="non-scaling-stroke"></path>
      <path fill="#FFFFFF" fill-rule="evenodd" stroke-width="0" d="M10.8,14.2h-1.7v-5h1.7v5Z" vector-effect="non-scaling-stroke"></path>
    </svg>
    <div>
      <a href="https://www.ssa.gov/manage-benefits/get-benefit-letter"><u>Get a benefit verification letter.</u></a>
    </div>
  </div>
</div>
<ssa-header class="print-dn"></ssa-header><script src="https://www.ssa.gov/legacy/components/dist/ssa-header.js"></script>
  <!-- MAIN CONTENT -->
  <main class="content" id="content" role="main">
    <!-- TITLE BAR -->
    <section class="bg-ivory-200">
      <!-- WRAPPER -->
      <div class="py2 wrapper">
        <h2 class="fw4 ma0" id="Top">Medical/Professional Relations</h2>
        </div>
    </section>

    <!-- WRAPPER -->
    <section class="wrapper">
    
    <!--GRID-->
<div class="grid">
	
<!-- FIRST COLUMN -->
<article class="cell w-100 m-w-100">
	
<!-- BREADCRUMBS -->
<nav class="breadcrumbs fs1" aria-label="Breadcrumbs">
  <ol>
    <li><a href="https://www.ssa.gov">SSA Home</a></li>
	<li><a href="https://www.ssa.gov/disability">Disability</a></li>
	<li><a href="../index.htm">Medical/Professional Relations</a></li>
	<li><a href="index.htm">Disability Evaluation Under Social Security</a></li>
	<li><a href="AdultListings.htm">Listing of Impairments - Adult Listings (Part A)</a></li> 
    <li aria-current="page">1.00 Musculoskeletal Disorders - Adult</li>
  </ol>
</nav>
</article><!--END FIRST COLUMN-->

<!-- FIRST COLUMN -->
<article class="cell w-100 m-w-20">

<p class="js-toggle"><a href="AdultListings.htm">Adult Listings (Part A)</a></p>
<p class="js-toggle"><a href="ChildhoodListings.htm">Childhood Listings (Part B)</a></p>
<p class="js-toggle"><a href="general-info.htm">General Information</a></p>
<p class="js-toggle"><a href="evidentiary.htm">Evidentiary Requirements</a></p>
<p class="js-toggle"><a href="listing-impairments.htm">Listing of Impairments (overview) </a></p>

<p class="js-toggle"><a href="revisions-rules.html">Revisions to Rules Regarding the Evaluation of Medical Evidence</a></p>

</article><!-- END FIRST COLUMN-->

<!--SECOND COLUMN-->
<article class="cell w-100 m-w-80">

                        <h2>
                            <span>
                                <b>
                                    Disability Evaluation Under Social Security<br>
                                    <br>
                                    1.00 Musculoskeletal Disorders - Adult<br>
                                    &nbsp;
                                </b>
                            </span>
                        </h2>
                        
                            <!--GRID-->
					<div class="grid">

                         <!--FIRST INNER COLUMN-->
                        <article class="cell w-100 m-w-20">

                            <u><b>Section</b></u><br>
                            <br>
                            <a href="#1_01">
                                <b>1.01</b><br>
                                Category of
                                Impairments, Musculoskeletal
                            </a><br>
                            <br>
                            <a href="#1_15">
                                <b>1.15</b><br>
                                Disorders of the skeletal spine resulting in compromise of a nerve root(s)
                            </a>
                            <br>
                            <br>

                            <a href="#1_16">
                                <b>1.16</b><br>
                                Lumbar spinal stenosis resulting in compromise of the cauda equina
                            </a>

                            <br>
                            <br>

                            <a href="#1_17">
                                <b>1.17</b><br>
                                Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
                            </a>

                            <br>
                            <br>

                            <a href="#1_18">
                                <b> 1.18</b>
                                <br>
                                Abnormality of a major joint(s) in any extremity
                            </a>

                            <br>
                            <br>

                            <a href="#1_19">
                                <b> 1.19</b> <br>
                                Pathologic fractures due to any cause
                            </a>

                            <br>
                            <br>

                            <a href="#1_20">
                                <b>1.20 </b>
                                <br>
                                Amputation due to any cause
                            </a>

                            <br>
                            <br>


                            <a href="#1_21">
                                <b>1.21</b>
                                <br>
                                Soft tissue injury or abnormality under continuing surgical management
                            </a>

                            <br>
                            <br>

                            <a href="#1_22">
                                <b>1.22 </b>
                                <br>
                                Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones
                            </a>

                            <br>
                            <br>


                            <a href="#1_23">
                                <b>1.23</b>
                                <br>
                                Non-healing or complex fracture of an upper extremity
                            </a>

                        </article><!--END FIRST INNER COLUMN-->

							<!--SECOND inner COLUMN-->
                    <article class="cell w-100 m-w-80">

                        <p id="1_00"><u><b>1.00 Musculoskeletal Disorders</b></u></p>
                        <p align="left" id="1_00A">
                            <span style="font-weight:bold;">A.</span> 
                            <span style="font-style:italic">Which musculoskeletal disorders do we evaluate under these listings?</span>
                        </p>
                        <p align="left" id="1_00A1">
                            1. We evaluate disorders of the skeletal spine (vertebral column) or of the upper 
                            or lower extremities that affect musculoskeletal functioning under these listings. We use the term “skeletal” when we are referring to the structure of the bony skeleton. 
                            The <span style="font-style:italic">skeletal spine</span> refers to the bony structures, ligaments, and discs making up the spine. 
                            We refer to the skeletal spine in some musculoskeletal listings to differentiate it from the 
                            <span style="font-style:italic">neurological spine</span> (see <a href="#1_00B1" title="Section 1.00 - Subsection B1">1.00B1</a>). 
                            Musculoskeletal disorders may be congenital or acquired, and may include deformities, amputations, or other abnormalities. 
                            These disorders may involve the bones or major joints; or the tendons, ligaments, muscles, or other soft tissues.
                        </p>
                        <p align="left" id="1_00A3">
                            2. We evaluate soft tissue injuries (including burns) or abnormalities that are under continuing surgical management 
                            (see <a href="#1_00O1" title="Section 1.00 - Subsection O1">1.00O1</a>). The injuries or abnormalities may affect any part of the body, including the face and skull.
                        </p>
                        <p align="left" id="1_00A3">
                            3. We evaluate curvatures of the skeletal spine that affect musculoskeletal functioning under <a href="#1_15" title="Section 1.15">1.15</a>.
                            If a curvature of the skeletal spine is under continuing surgical management (see <a href="#1_00O1" title="Section 1.00 - Subsection O1">1.00O1</a>),
                            we will evaluate it under <a href="#1_21" title="Section 1.21">1.21</a> using our rules for determining medical equivalence.
                            See §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1526.htm" target="_blank" title="Code of Federal Regulations section 404.1526">404.1526</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm" target="_blank" title="Code of Federal Regulations section 416.926">416.926</a> of this chapter.
                        </p>
                        <p align="left" id="1_00B"><span style="font-weight:bold;">B.</span> 
                            <span style="font-style:italic">Which related disorders do we evaluate under other listings?</span>
                        </p>
                        <p align="left" id="1_00B1">
                            1. We evaluate a disorder or injury of the skeletal spine that results in damage to, and neurological dysfunction of, 
                            the spinal cord and its associated nerves (for example, paraplegia or quadriplegia) 
                            under the listings in <a href="11.00-Neurological-Adult.htm#11_00" target="_blank" title="11.00 Neurological - Adult Page, Section 11.00">11.00</a>.
                        </p>
                        <p align="left" id="1_00B2">
                            2. We evaluate inflammatory arthritis (for example, rheumatoid arthritis) 
                            under the listings in <a href="14.00-Immune-Adult.htm#14_00" target="_blank" title="14.00 Immune System Disorders - Adult Page, Section 14.00">14.00</a>.
                        </p>
                        <p align="left" id="1_00B3">
                            3. We evaluate curvatures of the skeletal spine that interfere with your ability to breathe
                            under the listings in <a href="3.00-Respiratory-Adult.htm#3_00" target="_blank" title="3.00 Respiratory Disorders - Adult Page, Section 3.00">3.00</a>,
                            impair myocardial function under the listings in <a href="4.00-Cardiovascular-Adult.htm#4_00" target="_blank" title="4.00 Cardiovascular System - Adult Page, Section 4.00">4.00</a>,
                            or result in social withdrawal or depression under the listings in <a href="12.00-MentalDisorders-Adult.htm#12_00" target="_blank" title="12.00 Mental Disorders - Adult Page, Section 12.00">12.00</a>.
                        </p>
                        <p align="left" id="1_00B4">
                            4. We evaluate non-healing or pathological fractures due to cancer,
                            whether it is a primary site or metastases,
                            under the listings in <a href="13.00-NeoplasticDiseases-Malignant-Adult.htm#13_00" target="_blank" title="13.00 Cancer - Adult Page, Section 13.00">13.00</a>.
                        </p>
                        <p align="left" id="1_00B5">
                            5. We evaluate the leg pain associated with peripheral vascular claudication and foot ulceration associated with peripheral arterial disease
                            under the listings in <a href="4.00-Cardiovascular-Adult.htm#4_00" target="_blank" title="4.00 Cardiovascular System - Adult Page, Section 4.00">4.00</a>.
                        </p>
                        <p align="left" id="1_00B6">
                            6. We evaluate burns that do not require continuing surgical management 
                            under the listings in <a href="8.00-Skin-Adult.htm#8_00" target="_blank" title="8.00 Skin Disorders - Adult Page, Section 8.00">8.00</a>.
                        </p>
                        <p align="left" id="1_00C"><span style="font-weight:bold;">C.</span> 
                            <span style="font-style:italic">What evidence do we need to evaluate your musculoskeletal disorder?</span>
                        </p>
                        <p align="left" id="1_00C1">
                            1. <span style="font-style:italic">General.</span> We need objective medical evidence from an acceptable medical source to establish that you have a medically
                            determinable musculoskeletal disorder. We also need evidence from both medical and nonmedical sources, who can describe how you function,
                            to assess the severity and duration of your musculoskeletal disorder.
                            We will determine the extent and kinds of evidence we need from medical and nonmedical sources based on the individual facts about your disorder.
                            For our basic rules on evidence,
                            see §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1512.htm" target="_blank" title="Code of Federal Regulations section 404.1512">404.1512</a>,
                             <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1513.htm" target="_blank" title="Code of Federal Regulations section 404.1513">404.1513</a>,
                             <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1520b.htm" target="_blank" title="Code of Federal Regulations section 404.1520b">404.1520b</a>,
                             <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0912.htm" target="_blank" title="Code of Federal Regulations section 416.912">416.912</a>,
                             <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0913.htm" target="_blank" title="Code of Federal Regulations section 416.913">416.913</a>, and
                             <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0920b.htm" target="_blank" title="Code of Federal Regulations section 416.920b">416.920b</a> of this chapter.
                            For our rules on evidence about your symptoms,
                            see §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1529.htm" target="_blank" title="Code of Federal Regulations section 404.1529">404.1529</a>
                            and  <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm" target="_blank" title="Code of Federal Regulations section 416.929">416.929</a> of this chapter.
                        </p>
                        <p align="left" id="1_00C2">
                            2. <span style="font-style:italic">Physical examination report(s).</span> In the report(s) of your physical examination, 
                            we require a medical source’s detailed description of the orthopedic, neurologic, 
                            or other objective clinical findings appropriate to your specific musculoskeletal disorder from his or her direct observations during your physical examination. 
                            We will not accept a report of your statements about your symptoms and limitations in place of the medical source’s report of objective clinical findings. 
                            We will not use findings on imaging or other diagnostic tests 
                            (see <a href="#1_00C3" title="Section 1.00 - Subsection C3">1.00C3</a>) as a substitute for findings on physical examination.
                        </p>
                        <p align="left" id="1_00C2a">
                            a. When the medical source reports that a clinical test sign(s) is positive, unless we have evidence to the contrary, we will assume that he or she performed the test properly and accept the medical source’s interpretation of the test. For example, we will assume a straight-leg raising test was conducted properly (that is, in sitting and supine positions), even if the medical source does not specify the positions in which the test was performed.
                        </p>
                        <p align="left" id="1_00C2b">
                            b. If you use an assistive device (see <a href="#1_00C6" title="Section 1.00 - Subsection C6">1.00C6</a>), 
                            the report must support the medical need for the device.
                        </p>
                        <p align="left" id="1_00C2c">
                            c. If your musculoskeletal disorder causes a reduction in muscle strength, the report must document measurement of the strength of the muscle(s) in question. The measurement should be based on a muscle strength grading system that is considered medically acceptable based on your age and impairments. For example, a grading system of 0 to 5, with 0 indicating complete loss of strength and 5 indicating maximum strength or equivalent medically acceptable scale (see Table 1). Reduction in muscle strength is demonstrated by evidence that your muscle strength is less than active range of motion (ROM) against gravity with maximum resistance. If the reduction in muscle strength involves one or both of your hands, the report must also document measurements of grip and pinch strength.
                        </p>
                        <p align="center" style="font-style:italic;">
                            Table 1 - Grading System of Muscle Function
                        </p>
                        <table class="table table-bordered table-striped">
                            <tbody><tr>
                                <th width="56%" colspan="2"><p align="center">Grade</p></th>
                                <th width="43%">
                                    Function of the Muscle
                                </th>
                            </tr>
                            <tr>
                                <td width="27%"><p align="center">0</p></td>
                                <td width="28%"><p align="center">None</p></td>
                                <td width="43%"><p align="center">No visible or palpable contraction.</p></td>
                            </tr>
                            <tr>
                                <td width="27%"><p align="center">1</p></td>
                                <td width="28%"><p align="center">Trace</p></td>
                                <td width="43%"><p align="center">Visible or palpable contraction with no motion.</p></td>
                            </tr>
                            <tr>
                                <td width="27%"><p align="center">2</p></td>
                                <td width="28%"><p align="center">Poor</p></td>
                                <td width="43%"><p align="center">Active ROM with gravity eliminated.</p></td>
                            </tr>
                            <tr>
                                <td width="27%"><p align="center">3</p></td>
                                <td width="28%"><p align="center">Fair</p></td>
                                <td width="43%"><p align="center">Active ROM against gravity only, without resistance.</p></td>
                            </tr>
                            <tr>
                                <td width="27%"><p align="center">4</p></td>
                                <td width="28%"><p align="center">Good</p></td>
                                <td width="43%"><p align="center">Active ROM against gravity, moderate resistance.</p></td>
                            </tr>
                            <tr>
                                <td width="27%"><p align="center">5</p></td>
                                <td width="28%"><p align="center">Normal</p></td>
                                <td width="43%"><p align="center">Active ROM against gravity, maximum resistance.</p></td>
                            </tr>
                        </tbody></table>
                        <p align="left" id="1_00C3">
                            3. <span style="font-style:italic">Imaging and other diagnostic tests.</span>
                        </p>
                        <p align="left" id="1_00C3a">
                            a. <span style="font-style:italic">Imaging</span> refers to medical imaging techniques, such as x-ray, computed tomography (CT), magnetic resonance imaging (MRI), and radionuclide scanning. For the purpose of these listings, the imaging must be consistent with the prevailing state of medical knowledge and clinical practice as the proper technique to support the evaluation of the disorder.
                        </p>
                        <p align="left" id="1_00C3b">
                            b. Findings on imaging must have lasted, or be expected to last, for a continuous period of at least 12 months.
                        </p>
                        <p align="left" id="1_00C3c">
                            c. Imaging and other diagnostic tests can provide evidence of physical abnormalities; however, these abnormalities may correlate poorly with your symptoms, including pain, or with your musculoskeletal functioning. Accordingly, we will not use findings on imaging or other diagnostic tests as a substitute for findings on physical examination about your ability to function, nor can we infer severity or functional limitations based solely on such tests.
                        </p>
                        <p align="left" id="1_00C3d">
                            d. For our rules on purchasing imaging and other diagnostic tests,
                            see §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1519k.htm" target="_blank" title="Code of Federal Regulations section 404.1519k">404.1519k</a>, 
                            <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1519m.htm" target="_blank" title="Code of Federal Regulations section 404.1519m">404.1519m</a>, 
                            <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0919k.htm" target="_blank" title="Code of Federal Regulations section 416.919k">416.919k</a>, and 
                            <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0919m.htm" target="_blank" title="Code of Federal Regulations section 416.919m">416.919m</a> of this chapter.
                        </p>
                        <p align="left" id="1_00C4">
                            4. <span style="font-style:italic">Operative reports.</span> If you have had a surgical procedure, we need a copy of the operative report, including details of the findings at surgery and information about any medical complications that may have occurred. If we do not have the operative report, we need confirmatory evidence of the surgical procedure from a medical source (for example, detailed follow-up reports or notations in the medical records concerning the surgical procedure in your medical history).
                        </p>
                        <p align="left" id="1_00C5">
                            5. <span style="font-style:italic">Effects of treatment.</span>
                        </p>
                        <p align="left" id="1_00C5a">
                            a. <span style="font-style:italic">General.</span> Treatments for musculoskeletal disorders may have beneficial or adverse effects, and responses to treatment vary from person to person. We will evaluate all of the effects of treatment (including surgical treatment, medications, and therapy) on the symptoms, signs, and laboratory findings of your musculoskeletal disorder, and on your musculoskeletal functioning.
                        </p>
                        <p align="left" id="1_00C5b">
                            b. <span style="font-style:italic">Response to treatment.</span> To evaluate your musculoskeletal functioning in response to treatment, we need the following: A description, including the frequency of the administration, of your medications; the type and frequency of therapy you receive; and a description of your response to treatment and any complications you experience related to your musculoskeletal disorder. The effects of treatment may be temporary or long-term. We need information over a sufficient period to determine the effects of treatment on your current musculoskeletal functioning and permit reasonable projections about your future functioning. We will determine the amount of time that constitutes a sufficient period in consultation with a medical consultant on a case-by-case basis.  In some cases, we will need additional evidence to make an assessment about your response to treatment. Your musculoskeletal disorder may meet or medically equal one of these listings regardless of whether you were prescribed opioid medication, or whether you were prescribed opioid medication and did not follow this prescribed treatment.
                        </p>
                        <p align="left" id="1_00C6">
                            6. <span style="font-style:italic">Assistive devices.</span>
                        </p>
                        <p align="left" id="1_00C6a">
                            a. <span style="font-style:italic">General.</span> An assistive device, for the purposes of these listings, is any device that you use to improve your stability, dexterity,
                            or mobility. An assistive device can be worn
                            (see <a href="#1_00C6b" title="Section 1.00 - Subsection C6b">1.00C6b</a> and <a href="#1_00C6c" title="Section 1.00 - Subsection C6c">1.00C6c</a>),
                            hand-held (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>),
                            or used in a seated position (see <a href="#1_00C6e" title="Section 1.00 - Subsection C6e">1.00C6e</a>).
                            When we use the phrase “documented medical need,” we mean that there is evidence from a medical source that supports your medical need for an assistive device
                            (see <a href="#1_00C2b" title="Section 1.00 - Subsection C2b">1.00C2b</a>) for a continuous period of at least 12 months
                            (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>).
                            This evidence must describe any limitation(s) in your upper or lower extremity functioning and the circumstances for which you need to use the assistive device.
                            We do not require that you have a specific prescription for the assistive device.
                        </p>
                        <p align="left" id="1_00C6b">
                            b. <span style="font-style:italic">Prosthesis(es).</span> A prosthesis is a wearable device, such as an artificial limb, that takes the place of an absent body part.
                            If you have a prosthesis(es), we need evidence from a medical source documenting your ability to walk,
                            or perform fine and gross movements (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>),
                            with the prosthesis(es) in place. When amputation(s) involves one or both lower extremities,
                            it is not necessary for the medical source to evaluate your ability to walk without the prosthesis(es) in place.
                            If you cannot use your prosthesis(es) due to complications affecting your residual limb(s),
                            we need evidence from a medical source documenting the condition of your residual limb(s) and the medical basis for your inability to use the device(s).
                        </p>
                        <p align="left" id="1_00C6c">
                            c. <span style="font-style:italic">Orthosis(es).</span> An orthosis is a wearable device, such as a brace,
                            that prevents or corrects a dysfunction or deformity by aligning or supporting the affected body part.
                            If you have an orthosis(es), we need evidence from a medical source documenting your ability to walk,
                            or perform fine and gross movements (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>),
                            with the orthosis(es) in place. If you cannot use your orthosis(es),
                            we need evidence from a medical source documenting the medical basis for your inability to use the device(s).
                        </p>
                        <p align="left" id="1_00C6d">
                            d. <span style="font-style:italic">Hand-held assistive devices</span>. Hand-held assistive devices include walkers, canes, or crutches,
                            which you hold onto with your hand(s) to support or aid you in walking. When you use a one-handed, hand-held assistive device
                            (such as a cane) with one upper extremity to walk and you cannot use your other upper extremity for fine or gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>), the need for the assistive device limits the use of both upper extremities.
                            If you use a hand-held assistive device, we need evidence from a medical source describing how you walk with the device.
                        </p>
                        <p align="left" id="1_00C6e">
                            e. <span style="font-style:italic">Wheeled and seated mobility devices</span>. Wheeled and seated mobility devices are assistive devices that you use in a seated position,
                            such as manual wheelchairs, motorized wheelchairs, rollators, and power operated vehicles.
                            If you use a wheeled and seated mobility device,
                            we need evidence from a medical source describing the type of wheeled and seated mobility device that you use and how you use the assistive device including
                            any customizations or modifications to the assistive device itself or for your use of the assistive device.
                            For example, if you use a wheelchair that typically requires the use of both hands but has been customized for your use with one hand,
                            then we will evaluate your use of the assistive device using the criteria in <a href="#1_00E3b" title="Section 1.00 - Subsection E3b">1.00E3b</a>
                            and not <a href="#1_00E3a" title="Section 1.00 - Subsection E3a">1.00E3a</a>.
                        </p>
                        <p align="left" id="1_00C6ei">
                            (i) <span style="font-style:italic">Wheeled and seated mobility devices involving the use of both hands</span>. Some wheeled and seated mobility devices involve the use of both hands to use the assistive device (for example, most manual wheelchairs). If you use a wheeled and seated mobility device that involves the use of both hands, then the need for the assistive device limits the use of both upper extremities.
                        </p>
                        <p align="left" id="1_00C6eii">
                            (ii) <span style="font-style:italic">Wheeled and seated devices involving the use of one hand</span>.
                            Some wheeled and seated mobility devices involve the use of one hand to use the assistive device
                            (for example, most motorized wheelchairs). If you use a wheeled and seated mobility device that involves the use of one upper extremity
                            and you cannot use your other upper extremity for fine or gross movements (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>),
                            then the need for the assistive device limits the use of both upper extremities.
                        </p>
                        <p align="left" id="1_00C7">
                           7. <span style="font-style:italic">Longitudinal evidence</span>.
                        </p>
						<p align="left" id="1_00C7a">
                            a. The term <em>pandemic period</em> as used in <a href="#1_00C7c" title="Section 1.00 - Subsection C7c">1.00C7c</a> means the period beginning on April 2, 2021, and ending on May 11, 2025. The term <em>post-pandemic evaluation period</em> as used in <a href="#1_00C7c" title="Section 1.00 - Subsection C7c">1.00C7c</a> means the period beginning on May 12, 2025, and ending on May 11, 2029.
                        </p>
                        <p align="left" id="1_00C7b">
                            b. We generally need a longitudinal medical record to assess the severity and duration of your musculoskeletal disorder because the severity of symptoms, signs, and laboratory findings related to most musculoskeletal disorders may improve over time or respond to treatment. Evidence over an extended period will show whether your musculoskeletal functioning is improving, worsening, or unchanging.
                        </p>
                        <p align="left" id="1_00C7c">
                           c. For <a href="#1_15" title="Section 1.15">1.15</a>, <a href="#1_16" title="Section 1.16">1.16</a>, 
                            <a href="#1_17" title="Section 1.17">1.17</a>, <a href="#1_18" title="Section 1.18">1.18</a>, 
                            <a href="#1_20C" title="Section 1.20 - Subsection C">1.20C</a>, <a href="#1_20D" title="Section 1.20 - Subsection D">1.20D</a>, 
                            <a href="#1_22" title="Section 1.22">1.22</a>, and <a href="#1_23" title="Section 1.23">1.23</a>, 
                            all of the required criteria must be present simultaneously, or within a close proximity of time, to satisfy the level of severity needed to meet the listing. The phrase "within a close proximity of time" means that all of the relevant criteria must appear in the medical record within a consecutive 4-month period, except for claims determined or decided during the pandemic period or post-pandemic evaluation period. For claims determined or decided during the pandemic period or post-pandemic evaluation period, all of the relevant criteria must appear in the medical record within a consecutive 12-month period. When the criterion is imaging, we mean that we could reasonably expect the findings on imaging to have been present at the date of impairment or date of onset. For listings that use the word "and" to link the elements of the required criteria, the medical record must establish the simultaneous presence, or presence within a close proximity of time, of all the required medical criteria. Once this level of severity is established, the medical record must also show that this level of severity has continued, or is expected to continue, for a continuous period of at least 12 months.
                        </p>
                        <p align="left" id="1_00C8">
                            8. <span style="font-style:italic">Surgical treatment and physical therapy</span>. For some musculoskeletal disorders, a medical source may recommend surgery or physical therapy (PT).
                            If you have not yet had the recommended surgery or PT, we will not assume that these interventions will resolve your disorder or improve your functioning.
                            We will assess each case on an individual basis. Depending on your response to treatment, or your medical sources’ treatment plans,
                            we may defer our findings regarding the effect of surgery or PT, until a sufficient period has passed to permit proper consideration
                            or judgment about your future functioning. When necessary,
                            we will follow the rules on following prescribed treatment in
                            §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1530.htm" target="_blank" title="Code of Federal Regulations section 404.1530">404.1530</a> and 
                            <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0930.htm" target="_blank" title="Code of Federal Regulations section 416.930">416.930</a> of this chapter,
                            including consideration of your reasons for failure to follow prescribed treatment.
                        </p>
                        <p align="left" id="1_00D">
                            <span style="font-weight:bold;">D.</span> 
                            <span style="font-style:italic">How do we consider symptoms, including pain, under these listings?</span>
                        </p>
                        <p align="left" id="1_00D1">
                            1. Musculoskeletal disorders may cause pain or other symptoms; however,
                            your statements about your pain or other symptoms will not alone establish that you are disabled.
                            We will not substitute an alleged or a reported increase in the intensity of a symptom, such as pain, no matter how severe,
                            for a medical sign or diagnostic finding present in the listing criteria.
                            Pain is included as just one consideration in <a href="#1_15A" title="Section 1.15 - Subsection A">1.15A</a>
                            , <a href="#1_16A" title="Section 1.16 - Subsection A">1.16A</a>, and <a href="#1_18A" title="Section 1.18 - Subsection A">1.18A</a>,
                            but it is not required to satisfy the criteria in <a href="#1_15" title="Section 1.15">1.15</a>, <a href="#1_16" title="Section 1.16">1.16</a>, 
                            and <a href="#1_18" title="Section 1.18">1.18</a>.
                        </p>
                        <p align="left" id="1_00D2">
                            2. To consider your symptom(s),
                            we require objective medical evidence from an acceptable medical source showing the existence of a medically determinable musculoskeletal impairment that
                            we could reasonably expect to produce the symptom(s).
                            See §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1529.htm" target="_blank" title="Code of Federal Regulations section 404.1529">404.1529</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0929.htm" target="_blank" title="Code of Federal Regulations section 416.929">416.929</a>
                            of this chapter for how we evaluate symptoms, including pain, related to your musculoskeletal disorder.
                        </p>
                        <p align="left" id="1_00E">
                            <span style="font-weight:bold;">E.</span>
                            <span style="font-style:italic">How do we use the functional criteria to evaluate your musculoskeletal disorder under these listings?</span>
                        </p>
                        <p align="left" id="1_00E1">
                            1. <span style="font-style:italic">General</span>. The functional criteria are based on impairment-related physical limitations in your ability to use both upper extremities,
                            one or both lower extremities, or a combination of one upper and one lower extremity.
                            The required impairment-related physical limitation of musculoskeletal functioning must have lasted, or be expected to last,
                            for a continuous period of at least 12 months.
                            We do not use the functional criteria in <a href="#1_20A" title="Section 1.20 - Subsection A">1.20A</a>, <a href="#1_20B" title="Section 1.20 - Subsection B">1.20B</a>,
                            or <a href="#1_21" title="Section 1.21">1.21</a>.
                        </p>
                        <p align="left" id="1_00E2">
                            2. <span style="font-style:italic">Work environment</span>. We use the relevant evidence that we have to evaluate your musculoskeletal functioning with respect to the work environment rather than the home environment. For example, an ability to walk independently at home without an assistive device does not, in and of itself, indicate an ability to walk without an assistive device in a work environment.
                        </p>
                        <p align="left" id="1_00E3">
                            3. <span style="font-style:italic">Functional criteria</span>. A musculoskeletal disorder satisfies the functional criteria of a listing when the medical documentation shows the presence of at least one of the impairment-related limitations cited in the listing. The required impairment-related limitation of musculoskeletal functioning must be medically documented by one of the following:
                        </p>
                        <p align="left" id="1_00E3a">
                            a. A documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker,
                            bilateral canes, or bilateral crutches (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>)
                            or a wheeled and seated mobility device involving the use of both hands
                            (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>);
                        </p>
                        <p align="left" id="1_00E3b">
                            b. An inability to use one upper extremity to independently initiate, sustain, 
                            and complete work-related activities involving fine and gross movements 
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>), and a documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a one-handed, 
                            hand-held assistive device (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) that requires the use of your other upper extremity or a wheeled and seated mobility device involving the use of one hand 
                            (see <a href="#1_00C6eii" title="Section 1.00 - Subsection C6eii">1.00C6e(ii)</a>);
                        </p>
                        <p align="left" id="1_00E3c">
                            c. An inability to use both upper extremities to the extent that neither can be used to independently initiate, sustain, 
                            and complete work-related activities involving fine and gross movements 
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>).
                        </p>
                        <p align="left" id="1_00E4">
                            4. <span style="font-style:italic">Fine and gross movements. Fine</span> movements, for the purposes of these listings, 
                            involve use of your wrists, hands, and fingers; such movements include picking, pinching, manipulating, and fingering. 
                            <span style="font-style:italic">Gross</span> movements involve use of your shoulders, upper arms, forearms, and hands; 
                            such movements include handling, gripping, grasping, holding, turning, and reaching. 
                            Gross movements also include exertional abilities such as lifting, carrying, pushing, and pulling. 
                            Examples of performing fine and gross movements include, but are not limited to, taking care of personal hygiene, sorting and handling papers or files, 
                            and placing files in a file cabinet at or above waist level.
                        </p>
                        <p align="left" id="1_00F">
                            <span style="font-weight:bold;">F.</span> 
                            <span style="font-style:italic">
                                What do we consider when we evaluate disorders of the skeletal spine resulting in compromise of a nerve root(s)
                                (<a href="#1_15" title="Section 1.15">1.15</a>)?
                            </span>
                        </p>
                        <p align="left" id="1_00F1">
                            1. <span style="font-style:italic">General</span>. We consider musculoskeletal disorders such as herniated nucleus pulposus, spinal osteoarthritis (spondylosis),
                            vertebral slippage (spondylolisthesis), degenerative disc disease, facet arthritis, and vertebral fracture or dislocation. Spinal disorders may cause cervical
                            or lumbar spine dysfunction when abnormalities of the skeletal spine compromise nerve roots of the cervical spine, a nerve root of the lumbar spine,
                            or a nerve root of both cervical and lumbar spines. We consider spinal nerve disorders that originate in the nervous system (for example, spinal arachnoiditis),
                            under the neurological disorders body system, <a href="11.00-Neurological-Adult.htm#11_00" target="_blank" title="11.00 Neurological - Adult Page, Section 11.00">11.00</a>.
                        </p>
                        <p align="left" id="1_00F2">
                            2. <span style="font-style:italic">Compromise of a nerve root(s)</span>. Compromise of a nerve root, sometimes referred to as “nerve root impingement,” is a phrase used when a physical object, such as a tumor, herniated disc, foreign body, or arthritic spur, is pushing on the nerve root as seen on imaging or during surgery. It can occur when a musculoskeletal disorder produces irritation, inflammation, or compression of the nerve root(s) as it exits the skeletal spine between the vertebrae. Related symptoms must be associated with, or follow the path of, the affected nerve root(s).
                        </p>
                        <p align="left" id="1_00F2a">
                            a. <span style="font-style:italic">Compromise of unilateral nerve root of the cervical spine</span>. Compromise of a nerve root as it exits the cervical spine between the vertebrae may affect the functioning of the associated upper extremity. The physical examination reproduces the related symptoms based on radicular signs and clinical tests appropriate to the specific cervical nerve root (for example, a positive Spurling test).
                        </p>
                        <p align="left" id="1_00F2b">
                            b. <span style="font-style:italic">Compromise of bilateral nerve roots of the cervical spine</span>. Although uncommon, if compromise of a nerve root occurs on both sides of the cervical spinal column, functioning of both upper extremities may be limited.
                        </p>
                        <p align="left" id="1_00F2c">
                            c. <span style="font-style:italic">Compromise of a nerve root(s) of the lumbar spine</span>. Compromise of a nerve root as it exits the lumbar spine between the vertebrae may limit the functioning of the associated lower extremity. The physical examination reproduces the related symptoms based on radicular signs and clinical tests. When a nerve root of the lumbar spine is compromised, we require a positive straight-leg raising test (also known as a Lasègue test) in both supine and sitting positions appropriate to the specific lumbar nerve root that is compromised.
                        </p>
                        <p align="left" id="1_00G">
                            <span style="font-weight:bold;">G.</span> 
                            <span style="font-style:italic">
                                What do we consider when we evaluate lumbar spinal stenosis resulting in compromise of the cauda equina
                                (<a href="#1_16" title="Section 1.16">1.16</a>)?
                            </span>
                        </p>
                        <p align="left" id="1_00G1">
                            1. <span style="font-style:italic">General</span>. We consider how pain, sensory changes, and muscle weakness caused by compromise of the cauda equina due to lumbar spinal stenosis affect your functioning. The cauda equina is a bundle of nerve roots that descends from the lower part of the spinal cord. Lumbar spinal stenosis can compress the nerves of the cauda equina, causing sensory changes and muscle weakness that may affect your ability to stand or walk. Pain related to compromise of the cauda equina is nonradicular because it is not typically associated with a specific nerve root (as is radicular pain in the cervical or lumbar spine).
                        </p>
                        <p align="left" id="1_00G2">
                            2. <span style="font-style:italic">Compromise of the cauda equina</span> due to lumbar spinal stenosis can affect your ability to walk or stand because of neurogenic claudication (also known as pseudoclaudication), a condition usually causing nonradicular pain that starts in the low back and radiates bilaterally (or less commonly, unilaterally) into the buttocks and lower extremities (or extremity). Extension of the lumbar spine, which occurs when you walk or stand, may provoke the pain of neurogenic claudication. The pain may be relieved by forward flexion of the lumbar spine or by sitting. In contrast, the leg pain associated with peripheral vascular claudication results from inadequate arterial blood flow to a lower extremity. It occurs repeatedly and consistently when a person walks a certain distance and is relieved when the person rests.
                        </p>
                        <p align="left" id="1_00H">
                            <span style="font-weight:bold;">H.</span>
                            <span style="font-style:italic">
                                What do we consider when we evaluate reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
                                (<a href="#1_17" title="Section 1.17">1.17</a>)?
                            </span>
                        </p>
                        <p align="left" id="1_00H1">
                            1. <span style="font-style:italic">General</span>. We consider reconstructive surgery or surgical arthrodesis when an acceptable medical source(s) documents the surgical procedure(s) and associated medical treatments to restore function of, or eliminate motion in, the affected major weight-bearing joint. Reconstructive surgery may be done in a single procedure or a series of procedures directed toward the salvage or restoration of functional use of the affected joint.
                        </p>
                        <p align="left" id="1_00H2">
                            2. <span style="font-style:italic">Major weight-bearing joints</span> are the hip, knee, and ankle-foot. The ankle and foot are considered together as one major joint.
                        </p>
                        <p align="left" id="1_00H3">
                            3. <span style="font-style:italic">Surgical arthrodesis</span> is the artificial fusion of the bones that form a joint, essentially eliminating the joint.
                        </p>
                        <p align="left" id="1_00I">
                            <span style="font-weight:bold;">I.</span> 
                            <span style="font-style:italic">
                                What do we consider when we evaluate abnormality of a major joint(s) in any extremity
                                (<a href="#1_18" title="Section 1.18">1.18</a>)?
                            </span>
                        </p>
                        <p align="left" id="1_00I1">
                            1. <span style="font-style:italic">General</span>. We consider musculoskeletal disorders that produce anatomical abnormalities of major joints of the extremities, which result in functional abnormalities in the upper or lower extremities (for example, osteoarthritis, chronic infections of bones and joints, and surgical arthrodesis of a joint). Abnormalities of the joints include ligamentous laxity or rupture, soft tissue contracture, or tendon rupture, and can cause muscle weakness of the affected joint(s).
                        </p>
                        <p align="left" id="1_00I1a">
                            a. An <span style="font-style:italic">anatomical</span> abnormality is one that is readily observable by a medical source during a physical examination (for example, subluxation or contracture), or is present on imaging (for example, joint space narrowing, bony destruction, ankylosis, or deformity).
                        </p>
                        <p align="left" id="1_00I1b">
                            b. A <span style="font-style:italic">functional</span> abnormality is abnormal motion or instability of the affected joint(s), including limitation of motion, excessive motion (hypermobility), movement outside the normal plane of motion for the joint (for example, lateral deviation), or fixation of the affected joint(s).
                        </p>
                        <p align="left" id="1_00I2">
                            2. <span style="font-style:italic">Major joint of an upper extremity</span> refers to the shoulder, elbow, and wrist-hand. We consider the wrist and hand together as one major joint.
                        </p>
                        <p align="left" id="1_00I3">
                            3. <span style="font-style:italic">Major joint of a lower extremity</span> refers to the hip, knee, and ankle-foot. We consider the ankle and hindfoot together as one major joint.
                        </p>
                        <p align="left" id="1_00J">
                            <span style="font-weight:bold;">J.</span> 
                            <span style="font-style:italic">What do we consider when we evaluate pathologic fractures due to any cause (<a href="#1_19" title="Section 1.19">1.19</a>)?</span>
                            We consider pathologic fractures of the bones in the skeletal spine, extremities, or other parts of the skeletal system.
                            Pathologic fractures result from disorders that weaken the bones, making them vulnerable to breakage.
                            Pathologic fractures may occur with osteoporosis, osteogenesis imperfecta or any other skeletal dysplasias, side effects of medications,
                            and disorders of the endocrine or other body systems.
                            Under <a href="#1_19" title="Section 1.19">1.19</a>, the fractures must have occurred on separate,
                            distinct occasions, rather than multiple fractures occurring at the same time, but the fractures may affect the same bone(s) multiple times.
                            There is no required time that must elapse between the fractures, but all three must occur within a 12-month period; for example,
                            separate incidents may occur within hours or days of each other.
                            We evaluate non-healing or complex traumatic fractures without accompanying pathology under <a href="#1_22" title="Section 1.22">1.22</a>
                            or <a href="#1_23" title="Section 1.23">1.23</a>.
                        </p>
                        <p align="left" id="1_00K">
                            <span style="font-weight:bold;">K.</span>
                            <span style="font-style:italic">
                                What do we consider when we evaluate amputation due to any cause (<a href="#1_20" title="Section 1.20">1.20</a>)?
                            </span>
                        </p>
                        <p align="left" id="1_00K1">
                            1. <span style="font-style:italic">General.</span> We consider amputation (the full or partial loss or absence of any extremity) due to any cause including trauma,
                            congenital abnormality or absence, surgery for treatment of conditions such as cancer or infection, or complications of peripheral vascular disease or diabetes mellitus.
                        </p>
                        <p align="left" id="1_00K2">
                            2. <span style="font-style:italic">Amputation of both upper extremities (<a href="#1_20A" title="Section 1.20 - Subsection A">1.20A</a>).</span>
                            Under <a href="#1_20A" title="Section 1.20 - Subsection A">1.20A</a>, we consider upper extremity amputations that occur at any level at or above the wrists (carpal joints),
                            up to and including disarticulation of the shoulder (glenohumeral) joint.
                            If you have had both upper extremities amputated at any level at or above the wrists up to and including the shoulder,
                            your impairment satisfies the duration requirement in
                            §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1509.htm" target="_blank" title="Code of Federal Regulations section 404.1509">404.1509</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0909.htm" target="_blank" title="Code of Federal Regulations section 416.909">416.909</a> of this chapter.
                            For amputations below the wrist,
                            we will follow the rules described in <a href="#1_00S" title="Section 1.00 - Subsection S">1.00S</a>.
                            We do not evaluate amputations below the wrist under <a href="#1_20A" title="Section 1.20 - Subsection A">1.20A</a> because the resulting limitation of function of the thumb(s),
                            finger(s), or hand(s) will vary, depending on the extent of loss and corresponding effect on fine and gross movements.
                        </p>
                        <p align="left" id="1_00K3">
                            3. <span style="font-style:italic">Hemipelvectomy or hip disarticulation (<a href="#1_20B" title="Section 1.20 - Subsection B">1.20B</a>).</span>
                            Under <a href="#1_20B" title="Section 1.20 - Subsection B">1.20B</a>, we consider hemipelvectomy,
                            which involves amputation of an entire lower extremity through the sacroiliac joint, and hip disarticulation,
                            which involves amputation of an entire lower extremity through the hip joint capsule and closure of the remaining musculature over the exposed acetabular bone.
                            If you have had a hemipelvectomy or hip disarticulation,
                            your impairment satisfies the duration requirement in
                            §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1509.htm" target="_blank" title="Code of Federal Regulations section 404.1509">404.1509</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0909.htm" target="_blank" title="Code of Federal Regulations section 416.909">416.909</a> of this chapter.
                        </p>
                        <p align="left" id="1_00K4">
                            4. <span style="font-style:italic">Amputation of one upper extremity and one lower extremity (<a href="#1_20C" title="Section 1.20 - Subsection C">1.20C</a>). </span>
                            Under <a href="#1_20C" title="Section 1.20 - Subsection C">1.20C</a>, we consider the amputation of one upper extremity at any level at or above the wrist and one lower extremity at or above the ankle.
                            If you have a documented medical need for a one-handed, hand-held assistive device (such as a cane)
                            or a wheeled and seated mobility device involving the use of one hand (such as a motorized wheelchair),
                            then you must use your remaining upper extremity to hold the device, making the extremity unavailable to perform other fine and gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>).
                        </p>
                        <p align="left" id="1_00K5">
                            5. <span style="font-style:italic">
                                    Amputation of one lower extremity or both lower extremities with complications of the residual limb(s)
                                    (<a href="#1_20D" title="Section 1.20 - Subsection D">1.20D</a>).
                            </span> Under <a href="#1_20D" title="Section 1.20 - Subsection D">1.20D</a>,
                            we consider the amputation of one lower extremity or both lower extremities at or above the ankle.
                            We also consider the condition of your residual limb(s), whether you can wear a prosthesis(es)
                            (see <a href="#1_00C6b" title="Section 1.00 - Subsection C6b">1.00C6b</a>), and whether you have a documented medical need
                            (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a hand-held assistive device(s)
                            (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) or a wheeled and seated mobility device
                            (see <a href="#1_00C6e" title="Section 1.00 - Subsection C6e">1.00C6e</a>).
                            If you have a non-healing residual limb(s) and are receiving ongoing surgical treatment expected to re-establish or improve function,
                            and that ongoing surgical treatment has not ended, or is not expected to end, within at least 12 months of the initiation of the surgical management
                            (see <a href="#1_00L" title="Section 1.00 - Subsection L">1.00L</a>), we evaluate your musculoskeletal disorder under <a href="#1_21" title="Section 1.21">1.21</a>.
                        </p>
                        <p align="left" id="1_00L">
                            
                            <span style="font-weight:bold;">L.</span>
                            <span style="font-style:italic">
                                What do we consider when we evaluate soft tissue injuries or abnormalities under continuing surgical management
                                (<a href="#1_21" title="Section 1.21">1.21</a>)?
                            </span>
                        </p>
                        <p align="left" id="1_00L1">
                            1. <span style="font-style:italic">General.</span>
                        </p>
                        <p align="left" id="1_00L1a">
                            a. We consider any soft tissue injury or abnormality involving the soft tissues of the body, 
                            whether congenital or acquired, when an acceptable medical source(s) 
                            documents the need for ongoing surgical procedures and associated medical treatments to restore function of the affected body part(s) 
                            (see <a href="#1_00O1" title="Section 1.00 - Subsection O1">1.00O1</a>). Surgical management includes the surgery(ies) itself, 
                            as well as various post-surgical procedures, surgical complications, infections or other medical complications, 
                            related illnesses, or related treatments that delay your attainment of maximum benefit from therapy 
                            (see <a href="#1_00O2" title="Section 1.00 - Subsection O2">1.00O2</a>).
                        </p>
                        <p align="left" id="1_00L1b">
                            b. Surgical procedures and associated treatments typically take place over extended periods, which may render you unable to perform work-related activity on a sustained basis. To document such inability, we must have evidence from an acceptable medical source(s) confirming that the surgical management has continued, or is expected to continue, for at least 12 months from the date of the first surgical intervention. These procedures and treatments must be directed toward saving, reconstructing, or replacing the affected part of the body to re-establish or improve its function, and not for cosmetic appearances alone.
                        </p>
                        <p align="left" id="1_00L1c">
                            c. Examples include malformations, third- and fourth-degree burns, crush injuries, craniofacial injuries, avulsive injuries, and amputations with complications of the residual limb(s).
                        </p>
                        <p align="left" id="1_00L1d">
                            d. We evaluate skeletal spine abnormalities or injuries 
                            under <a href="#1_15" title="Section 1.15">1.15</a> or <a href="#1_16" title="Section 1.16">1.16</a>, as appropriate. 
                            We evaluate abnormalities or injuries of bones in the lower extremities 
                            under <a href="#1_17" title="Section 1.17">1.17</a>, <a href="#1_18" title="Section 1.18">1.18</a>, 
                            or <a href="#1_22" title="Section 1.22">1.22</a>. 
                            We evaluate abnormalities or injuries of bones in the upper extremities 
                            under <a href="#1_18" title="Section 1.18">1.18</a> or <a href="#1_23" title="Section 1.23">1.23</a>.
                        </p>
                        <p align="left" id="1_00L2">
                            2. <span style="font-style:italic">Documentation.</span> In addition to the objective medical evidence we need to establish your soft tissue injury or abnormality, we also need all of the following medically documented evidence about your continuing surgical management:
                        </p>
                        <p align="left" id="1_00L2a">
                            a. Operative reports and related laboratory findings;
                        </p>
                        <p align="left" id="1_00L2b">
                            b. Records of post-surgical procedures;
                        </p>
                        <p align="left" id="1_00L2c">
                            c. Records of any surgical or medical complications (for example, related infections or systemic illnesses);
                        </p>
                        <p align="left" id="1_00L2d">
                            d. Records of any prolonged post-operative recovery periods and related treatments (for example, surgeries and treatments for burns);
                        </p>
                        <p align="left" id="1_00L2e">
                            e. An acceptable medical source’s plans for additional surgeries; and
                        </p>
                        <p align="left" id="1_00L2f">
                            f. Records detailing any other factors that have delayed, or that an acceptable medical source expects to delay, the saving, restoring, or replacing of the involved part for a continuous period of at least 12 months following the initiation of the surgical management.
                        </p>
                        <p align="left" id="1_00L3">
                            3. <span style="font-style:italic">Burns.</span> Third- and fourth-degree burns damage or destroy nerve tissue,
                            reducing or preventing transmission of signals through those nerves.
                            Such burns frequently require multiple surgical procedures and related therapies to re-establish or improve function,
                            which we evaluate under <a href="#1_21" title="Section 1.21">1.21</a>.
                            When burns are no longer <span style="font-style:italic">under continuing surgical management</span> (see <a href="#1_00O1" title="Section 1.00 - Subsection O1">1.00O1</a>),
                            we evaluate the residual impairment(s). When the residual impairment(s) affects the musculoskeletal system, as often occurs in third- and fourth-degree burns,
                            it can result in permanent musculoskeletal tissue loss, joint contractures, or loss of extremities.
                            We will evaluate such impairments under the relevant musculoskeletal disorders listing,
                            for example, <a href="#1_18" title="Section 1.18">1.18</a> or <a href="#1_20" title="Section 1.20">1.20</a>.
                            When the residual impairment(s) involves another body system,
                            we will evaluate the impairment(s) under the listings in the relevant body system(s).
                        </p>
                        <p align="left" id="1_00L4">
                            4. <span style="font-style:italic">Craniofacial injuries.</span> Surgeons may treat craniofacial injuries with multiple surgical procedures. These injuries may affect vision, hearing, speech, and the initiation of the digestive process, including mastication. When the craniofacial injury-related residual impairment(s) involves another body system(s), we will evaluate the impairment(s) under the listings in the relevant body system(s).
                        </p>
                        <p align="left" id="1_00M">
                            <span style="font-weight:bold;">M.</span>
                            <span style="font-style:italic">
                                What do we consider when we evaluate non-healing or complex fractures of the femur, tibia, pelvis,
                                or one or more of the talocrural bones (<a href="#1_22" title="Section 1.22">1.22</a>)?
                            </span>
                        </p>
                        <p align="left" id="1_00M1">
                            1. <span style="font-style:italic">Non-healing fracture.</span> A non-healing (nonunion) fracture is a fracture that has failed to unite completely. Nonunion is usually established when a minimum of 9 months has elapsed since the injury and the fracture site has shown no, or minimal, progressive signs of healing for a minimum of 3 months.
                        </p>
                        <p align="left" id="1_00M2">
                            2. <span style="font-style:italic">Complex fracture.</span> A complex fracture is a fracture with one or more of the following:
                        </p>
                        <p align="left" id="1_00M2a">
                            a. Comminuted (broken into many pieces) bone fragments;
                        </p>
                        <p align="left" id="1_00M2b">
                            b. Multiple fractures in a single bone;
                        </p>
                        <p align="left" id="1_00M2c">
                            c. Bone loss due to severe trauma;
                        </p>
                        <p align="left" id="1_00M2d">
                            d. Damage to the surrounding soft tissue;
                        </p>
                        <p align="left" id="1_00M2e">
                            e. Severe cartilage damage to the associated joint; or
                        </p>
                        <p align="left" id="1_00M2f">
                            f. Dislocation of the associated joint.
                        </p>
                        <p align="left" id="1_00M3">
                            3. When a complex fracture involves soft tissue damage, 
                            the treatment may involve continuing surgical management to restore or improve functioning. 
                            In such cases, we may evaluate the fracture(s) under <a href="#1_21" title="Section 1.21">1.21</a>.
                        </p>
                        <p align="left" id="1_00N">
                            <span style="font-weight:bold;">N.</span>
                            <span style="font-style:italic">
                                What do we consider when we evaluate non-healing or complex fracture of an upper extremity
                                (<a href="#1_23" title="Section 1.23">1.23</a>)?
                            </span>
                        </p>
                        <p align="left" id="1_00N1">
                            1. <span style="font-style:italic">Non-healing fracture.</span> A non-healing (nonunion) fracture is a fracture that has failed to unite completely. Nonunion is usually established when a minimum of 9 months has elapsed since the injury and the fracture site has shown no, or minimal, progressive signs of healing for a minimum of 3 months.
                        </p>
                        <p align="left" id="1_00N2">
                            2. <span style="font-style:italic">Complex fracture.</span> A complex fracture is a fracture with one or more of the following:
                        </p>
                        <p align="left" id="1_00N2a">
                            a. Comminuted (broken into many pieces) bone fragments;
                        </p>
                        <p align="left" id="1_00N2b">
                            b. Multiple fractures in a single bone;
                        </p>
                        <p align="left" id="1_00N2c">
                            c. Bone loss due to severe trauma;
                        </p>
                        <p align="left" id="1_00N2d">
                            d. Damage to the surrounding soft tissue;
                        </p>
                        <p align="left" id="1_00N2e">
                            e. Severe cartilage damage to the associated joint; or
                        </p>
                        <p align="left" id="1_00N2f">
                            f. Dislocation of the associated joint.
                        </p>
                        <p align="left" id="1_00N3">
                            3. When a complex fracture involves soft tissue damage, 
                            the treatment may involve continuing surgical management to restore or improve functioning. 
                            In such cases, we may evaluate the fracture(s) under <a href="#1_21" title="Section 1.21">1.21</a>.
                        </p>
                        <p align="left" id="1_00O">
                            <span style="font-weight:bold;">O.</span>
                            <span style="font-style:italic">
                                How will we determine whether your soft tissue injury or abnormality or your upper extremity fracture is no longer under continuing surgical management
                                or you have received maximum benefit from therapy?
                            </span>
                        </p>
                        <p align="left" id="1_00O1">
                            1. We will determine that your soft tissue injury or abnormality, 
                            or your upper extremity fracture, is no longer <span style="font-style:italic">under continuing surgical management</span>, 
                            as used in <a href="#1_21" title="Section 1.21">1.21</a> and <a href="#1_23" title="Section 1.23">1.23</a>, 
                            when the last surgical procedure or medical treatment directed toward the re-establishment or improvement of function of the involved part has occurred.
                        </p>
                        <p align="left" id="1_00O2">
                            2. We will determine that you have received <span style="font-style:italic">maximum benefit from therapy</span>, 
                            as used in <a href="#1_21" title="Section 1.21">1.21</a>, 
                            if there are no significant changes in physical findings or on appropriate imaging for any 6-month period after the last surgical procedure or medical treatment. 
                            We may also determine that you have received maximum benefit from therapy if your medical source(s) indicates that further improvement 
                            is not expected after the last surgical procedure or medical treatment.
                        </p>
                        <p align="left" id="1_00O3">
                            3. When you have received maximum benefit from therapy, we will evaluate any impairment-related residual symptoms, signs, 
                            and laboratory findings (including those on imaging), any complications associated with your surgical procedures or medical treatments, 
                            and any residual limitations in your functioning (see <a href="#1_00S" title="Section 1.00 - Subsection S">1.00S</a>).
                        </p>
                        <p align="left" id="1_00P">
                            <span style="font-weight:bold;">P.</span>
                            <span style="font-style:italic">
                                How do we evaluate your musculoskeletal disorder if there is no record of ongoing treatment?
                            </span>
                        </p>
                        <p align="left" id="1_00P1">
                            1. Despite having a musculoskeletal disorder, you may not have received ongoing treatment,
                            may have just begun treatment, may not have access to prescribed medical treatment, or may not have an ongoing relationship with the medical community.
                            In any of these situations, you will not have a longitudinal medical record for us to review when we evaluate your disorder and we may ask you to attend
                            a consultative examination to determine the severity and potential duration of your disorder.
                            See §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1519a.htm#b" target="_blank" title="Code of Federal Regulations section 404.1519a - Subsection b">404.1519a(b)</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0919a.htm#b" target="_blank" title="Code of Federal Regulations section 416.919a - Subsection b">416.919a(b)</a>
                            of this chapter.
                        </p>
                        <p align="left" id="1_00P2">
                            2. In some instances, we may be able to assess the severity and duration of your musculoskeletal disorder based on your medical record 
                            and current evidence alone. If the information in your case record is not sufficient to show that you have a musculoskeletal disorder that meets the criteria 
                            of one of the musculoskeletal disorders listings, 
                            we will follow the rules described in <a href="#1_00S" title="Section 1.00 - Subsection S">1.00S</a>.
                        </p>
                        <p align="left" id="1_00Q">
                            <span style="font-weight:bold;">Q.</span> 
                            <span style="font-style:italic">How do we consider the effects of obesity when we evaluate your musculoskeletal disorder? </span>
                            Obesity is a medically determinable impairment that is often associated with musculoskeletal disorders. 
                            Obesity increases stress on weight-bearing joints and may contribute to limitation of the range of motion of the skeletal spine and extremities. 
                            The combined effects of obesity with a musculoskeletal disorder can be greater than the effects of each of the impairments considered separately. 
                            We consider the additional and cumulative effects of your obesity when we determine whether you have a severe musculoskeletal disorder, 
                            a listing-level musculoskeletal disorder, a combination of impairments that medically equals the severity of a listed impairment, 
                            and when we assess your residual functional capacity.
                        </p>
                        <p align="left" id="1_00R">
                            <span style="font-weight:bold;">R.</span>
                            <span style="font-style:italic">
                                How do we evaluate your musculoskeletal disorder if there is evidence establishing a substance use disorder?
                            </span>
                            If we find that you are disabled and there is medical evidence in your case record establishing that you have a substance use disorder,
                            we will determine whether your substance use disorder is a contributing factor material to the determination of disability.
                            See §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1535.htm" target="_blank" title="Code of Federal Regulations section 404.1535">404.1535</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0935.htm" target="_blank" title="Code of Federal Regulations section 416.935">416.935</a> of this chapter.
                        </p>
                        <p align="left" id="1_00S">
                            <span style="font-weight:bold;">S.</span> 
                            <span style="font-style:italic">
                                How do we evaluate musculoskeletal disorders that do not meet one of these listings?
                            </span>
                        </p>
                        <p align="left" id="1_00S1">
                            1. These listings are only examples of musculoskeletal disorders that we consider severe enough to prevent you from doing any gainful activity. 
                            If your impairment(s) does not meet the criteria of any of these listings, we must also consider whether you have an impairment(s) 
                            that meets the criteria of a listing in another body system.
                        </p>
                        <p align="left" id="1_00S2">
                            2. If you have a severe medically determinable impairment(s) that does not meet a listing,
                            we will determine whether your impairment(s) medically equals a listing.
                            See §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1526.htm" target="_blank" title="Code of Federal Regulations section 404.1526">404.1526</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0926.htm" target="_blank" title="Code of Federal Regulations section 416.926">416.926</a> of this chapter.
                            If your impairment(s) does not meet or medically equal a listing, you may or may not have the residual functional capacity to engage in substantial gainful activity.
                            We proceed to the fourth step and, if necessary, the fifth step of the sequential evaluation process
                            in §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1520.htm" target="_blank" title="Code of Federal Regulations section 404.1520">404.1520</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0920.htm" target="_blank" title="Code of Federal Regulations section 416.920">416.920</a> of this chapter.
                        </p>
                        <p align="left" id="1_00S3">
                            3. We use the rules in §§ <a href="https://www.ssa.gov/OP_Home/cfr20/404/404-1594.htm" target="_blank" title="Code of Federal Regulations section 404.1594">404.1594</a>
                            and <a href="https://www.ssa.gov/OP_Home/cfr20/416/416-0994.htm" target="_blank" title="Code of Federal Regulations section 416.994">416.994</a> of this chapter,
                            as appropriate, when we decide whether you continue to be disabled.
                        </p>
                        <p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b></p>
                        <p id="1_01">
                            <b>1.01 Category of Impairments, Musculoskeletal Disorders</b>
                        </p>
                        <p id="1_15">
                            
                            <b>1.15 <i>Disorders of the skeletal spine resulting in compromise of a nerve root(s)</i></b>
                            (see <a href="#1_00F" title="Section 1.00 - Subsection F">1.00F</a>), documented by A, B, C, <span style="font-style:italic">and</span> D:
                        </p>
                        <p align="left" id="1_15A">
                            <span style="font-weight:bold;">A.</span> Neuro-anatomic (radicular) distribution of one or more of the following <span style="font-style:italic">symptoms</span> 
                            consistent with compromise of the affected nerve root(s):
                        </p>
                        <p align="left" id="1_15A1">
                            1. Pain; or
                        </p>
                        <p align="left" id="1_15A2">
                            2. Paresthesia; or
                        </p>
                        <p align="left" id="1_15A3">
                            3. Muscle fatigue.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_15B">
                            <span style="font-weight:bold;">B.</span> Radicular distribution of neurological <span style="font-style:italic;">signs</span> present during physical examination
                            (see <a href="#1_00C2" title="Section 1.00 - Subsection C2">1.00C2</a>) or on a diagnostic test
                            (see <a href="#1_00C3" title="Section 1.00 - Subsection C3">1.00C3</a>) and evidenced by 1, 2, and either 3 or 4:
                        </p>
                        <p align="left" id="1_15B1">
                            1. Muscle weakness; and
                        </p>
                        <p align="left" id="1_15B2">
                            2. Sign(s) of nerve root irritation, tension, or compression, consistent with compromise of the affected nerve root
                            (see <a href="#1_00F2" title="Section 1.00 - Subsection F2">1.00F2</a>); and
                        </p>
                        <p align="left" id="1_15B3">
                            3. Sensory changes evidenced by:
                        </p>
                        <p align="left" id="1_15B3a">
                            a. Decreased sensation; or
                        </p>
                        <p align="left" id="1_15B3b">
                            b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing; <span style="font-style:italic;">or</span>
                        </p>
                        <p align="left" id="1_15B4">
                            4. Decreased deep tendon reflexes.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_15C">
                            <span style="font-weight:bold;">C.</span> Findings on imaging
                            (see <a href="#1_00C3" title="Section 1.00 - Subsection C3">1.00C3</a>) consistent with compromise of a nerve root(s) in the cervical or lumbosacral spine.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_15D">
                            <span style="font-weight:bold;">D.</span> Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                            or is expected to last, for a continuous period of at least 12 months, 
                            and medical documentation of at least <span style="font-style:italic;">one</span> of the following:
                        </p>
                        <p align="left" id="1_15D1">
                            1. A documented medical need
                            (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker, bilateral canes, or bilateral crutches
                            (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) or a wheeled and seated mobility device involving the use of both hands
                            (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>); or
                        </p>
                        <p align="left" id="1_15D2">
                            2. An inability to use <span style="font-style:italic">one</span> upper extremity to independently initiate, sustain, 
                            and complete work-related activities involving fine and gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>), <span style="font-style:italic">and</span> a documented medical need
                            (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a one-handed,
                            hand-held assistive device (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>)
                            that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                            (see <a href="#1_00C6eii" title="Section 1.00 - Subsection C6eii">1.00C6e(ii)</a>); or
                        </p>
                        <p align="left" id="1_15D3">
                            3. An inability to use <span style="font-style:italic">both</span> upper extremities to the extent that neither can be used to independently initiate, sustain, 
                            and complete work-related activities involving fine and gross movements (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>).
                        </p>
                        <p align="left" id="1_16">
                            <b>
                                1.16
                                <i>
                                    Lumbar spinal stenosis resulting in compromise of the cauda equina
                                </i>
                            </b>(see <a href="#1_00G" title="Section 1.00 - Subsection G">1.00G</a>), documented by A, B, C, <span style="font-style:italic">and</span> D:
                        </p>
                        <p align="left" id="1_16A">
                            <span style="font-weight:bold;">A.</span> Symptom(s) of neurological compromise manifested as:
                        </p>
                        <p align="left" id="1_16A1">
                            1. Nonradicular distribution of pain in one or both lower extremities; or
                        </p>
                        <p align="left" id="1_16A2">
                            2. Nonradicular distribution of sensory loss in one or both lower extremities; or
                        </p>
                        <p align="left" id="1_16A3">
                            3. Neurogenic claudication.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_16B">
                            <span style="font-weight:bold;">B.</span> Nonradicular neurological signs present during physical examination
                            (see <a href="#1_00C2" title="Section 1.00 - Subsection C2">1.00C2</a>) or on a diagnostic test
                            (see <a href="#1_00C3" title="Section 1.00 - Subsection C3">1.00C3</a>) and evidenced by 1 and either 2 or 3:
                        </p>
                        <p align="left" id="1_16B1">
                            1. Muscle weakness.
                        </p>
                        <p align="left" id="1_16B2">
                            2. Sensory changes evidenced by:
                        </p>
                        <p align="left" id="1_16B2a">
                            a. Decreased sensation; or
                        </p>
                        <p align="left" id="1_16B2b">
                            b. Sensory nerve deficit (abnormal sensory nerve latency) on electrodiagnostic testing; or
                        </p>
                        <p align="left" id="1_16B2c">
                            c. Areflexia, trophic ulceration, or bladder or bowel incontinence.
                        </p>
                        <p align="left" id="1_16B3">
                            3. Decreased deep tendon reflexes in one or both lower extremities.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_16C">
                            <span style="font-weight:bold;">C.</span> Findings on imaging (see <a href="#1_00C3" title="Section 1.00 - Subsection C3">1.00C3</a>) or in an operative report
                            (see <a href="#1_00C4" title="Section 1.00 - Subsection C4">1.00C4</a>) consistent with compromise of the cauda equina with lumbar spinal stenosis.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_16D">
                            <span style="font-weight:bold;">D.</span> Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                            or is expected to last, for a continuous period of at least 12 months, 
                            and medical documentation of at least <span style="font-style:italic">one</span> of the following:
                        </p>
                        <p align="left" id="1_16D1">
                            1. A documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker,
                            bilateral canes, or bilateral crutches
                            (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) or a wheeled and seated mobility device involving the use of both hands
                            (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>); or
                        </p>
                        <p align="left" id="1_16D2">
                            2. An inability to use <span style="font-style:italic">one</span> upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>), <span style="font-style:italic">and</span> a documented medical need
                            (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a one-handed, hand-held assistive device
                            (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                            (see <a href="#1_00C6eii" title="Section 1.00 - Subsection C6eii">1.00C6e(ii)</a>).
                        </p>
                        <p align="left" id="1_17">
                            <b>
                                1.17
                                <i>
                                    Reconstructive surgery or surgical arthrodesis of a major weight-bearing joint
                                </i>
                            </b>(see <a href="#1_00H" title="Section 1.00 - Subsection H">1.00H</a>), documented by A, B, <span style="font-style:italic">and</span> C:
                        </p>
                        <p align="left" id="1_17A">
                            <span style="font-weight:bold;">A.</span> History of reconstructive surgery or surgical arthrodesis of a major weight-bearing joint.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_17B">
                            <span style="font-weight:bold;">B.</span> Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_17C">
                            <span style="font-weight:bold;">C.</span> A documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker,
                            bilateral canes, or bilateral crutches
                            (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) or a wheeled and seated mobility device involving the use of both hands
                            (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>).
                        </p>
                        <p align="left" id="1_18">
                            <b>
                                1.18
                                <i>
                                    Abnormality of a major joint(s) in any extremity
                                </i>
                            </b>(see <a href="#1_00I" title="Section 1.00 - Subsection I">1.00I</a>), documented by A, B, C, <span style="font-style:italic">and</span> D:
                        </p>
                        <p align="left" id="1_18A">
                            <span style="font-weight:bold;">A.</span> Chronic joint pain or stiffness.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_18B">
                            <span style="font-weight:bold;">B.</span> Abnormal motion, instability, or immobility of the affected joint(s).
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_18C">
                            <span style="font-weight:bold;">C.</span> Anatomical abnormality of the affected joint(s) noted on:
                        </p>
                        <p align="left" id="1_18C1">
                            1. Physical examination (for example, subluxation, contracture, or bony or fibrous ankylosis); or
                        </p>
                        <p align="left" id="1_18C2">
                            2. Imaging (for example, joint space narrowing, bony destruction, or ankylosis or arthrodesis of the affected joint).
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_18D">
                            <span style="font-weight:bold;">D.</span> Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                            or is expected to last, for a continuous period of at least 12 months, 
                            and medical documentation of at least <span style="font-style:italic">one</span> of the following:
                        </p>
                        <p align="left" id="1_18D1">
                            1. A documented medical need
                            (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker, bilateral canes, or bilateral crutches
                            (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) or a wheeled and seated mobility device involving the use of both hands
                            (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>); or
                        </p>
                        <p align="left" id="1_18D2">
                            2. An inability to use <span style="font-style:italic">one</span> upper extremity to independently initiate, sustain, 
                            and complete work-related activities involving fine and gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>),
                            <span style="font-style:italic">and</span> a documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a one-handed,
                            hand-held assistive device
                            (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                            (see <a href="#1_00C6eii" title="Section 1.00 - Subsection C6eii">1.00C6e(ii)</a>); or
                        </p> 
                        <p align="left" id="1_18D3">
                            3. An inability to use <span style="font-style:italic">both</span> upper extremities to the extent that neither can be used to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>).
                        </p>
                        <p align="left" id="1_19">
                            <b>
                               1.19
                                <i>
                                    Pathologic fractures due to any cause
                                </i>
                            </b>(see <a href="#1_00J" title="Section 1.00 - Subsection J">1.00J</a>), documented by A <span style="font-style:italic">and</span> B:
                        </p>
                        <p align="left" id="1_19A">
                            <span style="font-weight:bold;">A.</span> Pathologic fractures occurring on three separate occasions within a 12-month period.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_19B">
                            <span style="font-weight:bold;">B.</span> Impairment-related physical limitation of musculoskeletal functioning that has lasted, 
                            or is expected to last, for a continuous period of at least 12 months, 
                            and medical documentation of at least <span style="font-style:italic">one</span> of the following:
                        </p>
                        <p align="left" id="1_19B1">
                            1. A documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker,
                            bilateral canes, or bilateral crutches (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>)
                            or a wheeled and seated mobility device involving the use of both hands (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>); or
                        </p>
                        <p align="left" id="1_19B2">
                            2. An inability to use <span style="font-style:italic">one</span> upper extremity to independently initiate, sustain, 
                            and complete work-related activities involving fine and gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>),
                            <span style="font-style:italic">and</span> a documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a one-handed,
                            hand-held assistive device (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>)
                            that requires the use of the other upper extremity or a wheeled and seated mobility device involving the use of one hand
                            (see <a href="#1_00C6eii" title="Section 1.00 - Subsection C6eii">1.00C6e(ii)</a>); or
                        </p>
                        <p align="left" id="1_19B3">
                            3. An inability to use <span style="font-style:italic">both</span> upper extremities to the extent that neither can be used to independently initiate, 
                            sustain, and complete work-related activities involving fine and gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>).
                        </p>
                        <p align="left" id="1_20">
                            <b>
                                1.20
                                <i>
                                    Amputation due to any cause
                                </i>
                            </b>(see <a href="#1_00K" title="Section 1.00 - Subsection K">1.00K</a>), documented by A, B, C, <span style="font-style:italic">or</span> D:
                        </p>
                        <p align="left" id="1_20A">
                            <span style="font-weight:bold;">A.</span> Amputation of both upper extremities, occurring at any level at or above the wrists (carpal joints), up to and including the shoulder (glenohumeral) joint.
                        </p>
                        <p align="left">OR</p>
                        <p align="left" id="1_20B">
                            <span style="font-weight:bold;">B.</span> Hemipelvectomy or hip disarticulation.
                        </p>
                        <p align="left">OR</p>
                        <p align="left" id="1_20C">
                            <span style="font-weight:bold;">C.</span> Amputation of one upper extremity, occurring at any level at or above the wrist (carpal joints), 
                            and amputation of one lower extremity, occurring at or above the ankle (talocrural joint), 
                            <span style="font-style:italic">and</span> medical documentation of at least <span style="font-style:italic">one</span> of the following:
                        </p>
                        <p align="left" id="1_20C1">
                            1. A documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker,
                            bilateral canes, or bilateral crutches (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>)
                            or a wheeled and seated mobility device involving the use of both hands
                            (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>); or
                        </p>
                        <p align="left" id="1_20C2">
                            2. A documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a one-handed,
                            hand-held assistive device (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>) requiring the use of the other upper extremity
                            or a wheeled and seated mobility device involving the use of one hand
                            (see <a href="#1_00C6eii" title="Section 1.00 - Subsection C6eii">1.00C6e(ii)</a>); or
                        </p>
                        <p align="left" id="1_20C3">
                            3. The inability to use the remaining upper extremity to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                            (<a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>).
                        </p>
                        <p align="left">OR</p>
                        <p align="left" id="1_20D">
                            <span style="font-weight:bold;">D.</span> Amputation of one or both lower extremities, occurring at or above the ankle (talocrural joint), 
                            with complications of the residual limb(s) that have lasted, or are expected to last, 
                            for a continuous period of at least 12 months, <span style="font-style:italic">and</span> medical documentation of 1 and 2:
                        </p>
                        <p align="left" id="1_20D1">
                            1. The inability to use a prosthesis(es); and
                        </p>
                        <p align="left" id="1_20D2">
                            2. A documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker,
                            bilateral canes, or bilateral crutches (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>)
                            or a wheeled and seated mobility device involving the use of both hands (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>).
                        </p>
                        <p align="left" id="1_21">
                            <b>
                                1.21
                                <i>
                                    Soft tissue injury or abnormality under continuing surgical management
                                </i>
                            </b>(see <a href="#1_00L" title="Section 1.00 - Subsection L">1.00L</a>), documented by A, B, <span style="font-style:italic">and</span> C:
                        </p>
                        <p align="left" id="1_21A">
                            <span style="font-weight:bold;">A.</span> Evidence confirms continuing surgical management
                            (see <a href="#1_00P1" title="Section 1.00 - Subsection O1">1.00O1</a>) directed toward saving, reconstructing, or replacing the affected part of the body.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_21B">
                            <span style="font-weight:bold;">B.</span> The surgical management has been, or is expected to be, ongoing for a continuous period of at least 12 months.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_21C">
                            <span style="font-weight:bold;">C.</span> Maximum benefit from therapy (see <a href="#1_00O2" title="Section 1.00 - Subsection O2">1.00O2</a>) has not yet been achieved.
                        </p>
                        <p align="left" id="1_22">
                            <b>
                                1.22
                                <i>
                                    Non-healing or complex fracture of the femur, tibia, pelvis, or one or more of the talocrural bones
                                </i>
                            </b>(see <a href="#1_00M" title="Section 1.00 - Subsection M">1.00M</a>), documented by A, B, <span style="font-style:italic">and</span> C:
                        </p>
                        <p align="left" id="1_22A">
                            <span style="font-weight:bold;">A.</span> Solid union not evident on imaging (see <a href="#1_00C3" title="Section 1.00 - Subsection C3">1.00C3</a>) and not clinically solid.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_22B">
                            <span style="font-weight:bold;">B.</span> Impairment-related physical limitation of musculoskeletal functioning that has lasted, or is expected to last, for a continuous period of at least 12 months.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_22C">
                            <span style="font-weight:bold;">C.</span> A documented medical need (see <a href="#1_00C6a" title="Section 1.00 - Subsection C6a">1.00C6a</a>) for a walker,
                            bilateral canes, or bilateral crutches (see <a href="#1_00C6d" title="Section 1.00 - Subsection C6d">1.00C6d</a>)
                            or a wheeled and seated mobility device involving the use of both hands (see <a href="#1_00C6ei" title="Section 1.00 - Subsection C6ei">1.00C6e(i)</a>).
                        </p>
                        <p align="left" id="1_23">
                            <b>
                                1.23
                                <i>
                                    Non-healing or complex fracture of an upper extremity
                                </i>
                            </b>(see <a href="#1_00N" title="Section 1.00 - Subsection N">1.00N</a>), documented by A <span style="font-style:italic">and</span> B:
                        </p>
                        <p align="left" id="1_23A">
                            <span style="font-weight:bold;">A.</span> Nonunion or complex fracture of the shaft of the humerus, radius, or ulna, under continuing surgical management
                            (see <a href="#1_00P1" title="Section 1.00 - Subsection O1">1.00O1)</a> directed toward restoration of functional use of the extremity.
                        </p>
                        <p align="left">AND</p>
                        <p align="left" id="1_23B">
                            <span style="font-weight:bold;">B.</span> Medical documentation of an inability to independently initiate, sustain, and complete work-related activities involving fine and gross movements
                            (see <a href="#1_00E4" title="Section 1.00 - Subsection E4">1.00E4</a>) that has lasted, or is expected to last, for a continuous period of at least 12 months.
                        </p>
                        
                        <p align="center"><b><a href="#Top" class="seventypercent">Back to Top</a></b></p>

                    </article><!-- END SECOND INNER COLUMN -->
 
 </div><!-- END GRID-->

</article><!-- END SECOND COLUMN -->

</div><!-- END GRID-->

    </section>
  </main>
  <!-- FOOTER -->
  <ssa-footer class="print-dn"></ssa-footer><script src="https://www.ssa.gov/legacy/components/dist/ssa-footer.js"></script>
  <!-- SCRIPTS -->
  <script src="/framework/js/ssa.firefly.body.js"></script><a class="js-btt" href="#" title="Back to Top"></a>



</body></html>